Results 1 to 10 of about 126,662 (215)

A multivariable prediction model combining 18F-PSMA PET/CT and mpMRI for clinically significant prostate cancer: development and validation [PDF]

Frontiers in Oncology
BackgroundMultiparametric MRI (mpMRI) and prostate-specific membrane antigen (PSMA) PET/CT provide complementary information for prostate cancer diagnosis, but optimal integration strategies remain unclear.
Chaojian Yu, Chaojian Yu, Chaojian Yu, Zihou Zhao, Zihou Zhao, Zihou Zhao, Peidong Tian, Peidong Tian, Peidong Tian, Jingcheng Zhou, Jingcheng Zhou, Jingcheng Zhou, Lin Cai, Lin Cai, Lin Cai, Jianhui Qiu, Jianhui Qiu, Jianhui Qiu, Kan Gong, Kan Gong, Kan Gong   +20 more
doaj   +2 more sources

Lesional volume in the prediction of clinically significant prostate cancer [PDF]

World Journal of Surgical Oncology
Background While MRI has significantly advanced risk stratification in prostate cancer, PIRADS scoring alone is still insufficient to solely determine which patients do not require biopsy.
Bellamy Brodie, Daniel Yang Yao Peh, Yu Guang Tan, Yan Mee Law, Kae Jack Tay, Christopher Wai Sam Cheng, Henry Sun Sien Ho, John Shyi Peng Yuen, Alvin Yuan Ming Lee, Kenneth Chen   +9 more
doaj   +2 more sources

Radiomic Machine-Learning Analysis of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: New Combination of Textural and Clinical Features

Current Oncology, 2023
Background: The aim of our study was to develop a radiomic tool for the prediction of clinically significant prostate cancer. Methods: From September 2020 to December 2021, 91 patients who underwent magnetic resonance imaging prostate fusion biopsy at ...
Francesco Prata, Umberto Anceschi, Ermanno Cordelli, Eliodoro Faiella, Angelo Civitella, Piergiorgio Tuzzolo, Andrea Iannuzzi, Alberto Ragusa, Francesco Esperto, Salvatore Mario Prata, Rosa Sicilia, Giovanni Muto, Rosario Francesco Grasso, Roberto Mario Scarpa, Paolo Soda, Giuseppe Simone, Rocco Papalia   +16 more
doaj   +1 more source

68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone

Cancer Imaging, 2023
Background The prostate-specific antigen (PSA) has been widely used in screening and early diagnosis of prostate cancer (PCa). However, in the PSA grey zone of 4–10 ng/ml, the sensitivity and specificity for diagnosing PCa are limited, resulting in ...
Jinhui Yang, Jian Li, Ling Xiao, Ming Zhou, Zhihui Fang, Yi Cai, Yongxiang Tang, Shuo Hu   +7 more
doaj   +1 more source

Novel radiomic analysis on bi-parametric MRI for characterizing differences between MR non-visible and visible clinically significant prostate cancer

European Journal of Radiology Open, 2023
Background: around one third of clinically significant prostate cancer (CsPCa) foci are reported to be MRI non-visible (MRI─). Objective: To quantify the differences between MR visible (MRI+) and MRI─ CsPCa using intra- and peri-lesional radiomic ...
Lin Li, Rakesh Shiradkar, Sree Harsha Tirumani, Leonardo Kayat Bittencourt, Pingfu Fu, Amr Mahran, Christina Buzzy, Phillip D. Stricker, Ardeshir R. Rastinehad, Cristina Magi-Galluzzi, Lee Ponsky, Eric Klein, Andrei S. Purysko, Anant Madabhushi   +13 more
doaj   +1 more source

Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients?

Frontiers in Oncology, 2021
BackgroundEuropean Association of Urology (EAU) guidelines recommend using risk-calculators (RCs), imaging or additional biomarkers in asymptomatic men at risk of prostate cancer (PCa).ObjectivesTo compare the performance of mpMRI, a RC we recently ...
Ugo Giovanni Falagario, Giovanni Silecchia, Salvatore Mariano Bruno, Michele Di Nauta, Mario Auciello, Mario Auciello, Francesca Sanguedolce, Paola Milillo, Luca Macarini, Oscar Selvaggio, Giuseppe Carrieri, Luigi Cormio, Luigi Cormio   +12 more
doaj   +1 more source

Importance of Malignant Core Length in the Detection of Clinically Significant Prostate Cancer in Transrectal Prostate Biopsies

Journal of Urological Surgery, 2023
Objective:To examine cores obtained using prostate biopsy under transrectal ultrasound guidance and determine the ideal total malignant core length for the diagnosis of clinically significant prostate cancer (PCa).Materials and Methods:From the beginning
Gökçe Dündar, Anıl Erkan
doaj   +1 more source

Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram

Frontiers in Oncology, 2022
ObjectiveTo develop and validate a multimodal MRI-based radiomics nomogram for predicting clinically significant prostate cancer (CS-PCa).MethodsPatients who underwent radical prostatectomy with pre-biopsy prostate MRI in three different centers were ...
Guodong Jing, Pengyi Xing, Zhihui Li, Xiaolu Ma, Haidi Lu, Chengwei Shao, Yong Lu, Jianping Lu, Fu Shen   +8 more
doaj   +1 more source

The Application of Biopsy Density in Transperineal Templated-Guided Biopsy Patients With PI-RADS<3

Frontiers in Oncology, 2022
BackgroundIn patients with multiparameter magnetic resonance imaging (mpMRI) low-possibility but highly clinical suspicion of prostate cancer, the biopsy core is unclear.
Hai Zhu, Hai Zhu, Xue-fei Ding, Xue-fei Ding, Sheng-ming Lu, Ning Ding, Shi-yi Pi, Zhen Liu, Qin Xiao, Liang-yong Zhu, Yang Luan, Yue-xing Han, Hao-peng Chen, Zhong Liu   +13 more
doaj   +1 more source

Prostate Health Index Density Outperforms Prostate Health Index in Clinically Significant Prostate Cancer Detection

Frontiers in Oncology, 2021
BackgroundProstate-specific antigen (PSA) is considered neither sensitive nor specific for prostate cancer (PCa). We aimed to compare total PSA (tPSA), percentage of free PSA (%fPSA), the PSA density (PSAD), Prostate Health Index (PHI), and the PHI ...
Shih-Ting Chiu, Yung-Ting Cheng, Yeong-Shiau Pu, Yu-Chuan Lu, Jian-Hua Hong, Shiu-Dong Chung, Shiu-Dong Chung, Chih-Hung Chiang, Chih-Hung Chiang, Chih-Hung Chiang, Chao-Yuan Huang   +10 more
doaj   +1 more source